Blog
Evidence-based longevity medicine. RSS
-
What I'd do with $100M to maximally disrupt healthcare
A 13-bet capital allocation thesis: prize capital, organ-specific rejuvenation trials, and biostasis as the terminal optionality bet — engineered for peer-reviewed evidence of multi-organ age reversal by 2030.
-
11 biomarkers most people (and many doctors) miss
From Lp(a) and free testosterone to CBCT airway imaging and 24/7 blood pressure — the longevity tests routinely skipped in standard care, with how to access them.
-
Welcome to the Zolman Longevity Blog
Evidence-based longevity medicine, n=1 trial design, and 82-organ rejuvenation — explained without hype.